Clinical trial
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in Patients Treated With Antiretroviral Drugs - an Observational Cohort Study.
NCT06044792 is registered in ClinicalTrials.gov with Medical University of Warsaw as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in Patients Treated With Antiretroviral Drugs - an Observational Cohort Study.
- Lead sponsor
- Medical University of Warsaw
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 30, 2023
- Completion date
- January 1, 2028
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
aids, art, cd4 deficiency, hiv, treatment resistant disorders, treatment-sensitive hiv infection